Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Radialis is a private medical device company developing and commercializing organ-targeted positron emission tomography imaging systems. Its lead product, the Radialis PET Imager, is an FDA-cleared, small-field-of-view PET camera designed to generate high-resolution images of specific organs while using low radiotracer doses. The company positions the system as a complement to conventional whole-body PET/CT, with particular emphasis on breast imaging, treatment planning for primary solid tumors, and future low-dose molecular imaging applications. Radialis' technology originated from research at Lakehead University and the Thunder Bay Regional Health Research Institute, and the company manufactures medical devices in Thunder Bay, Ontario. In addition to commercial deployment, Radialis has supported clinical research including breast cancer imaging studies such as the bCOMBAT work and positron emission mammography studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Radialis.